Perception of castration value over cost in the metastatic prostate cancer scenario: a contemporary pharmacoeconomic perspective

AUTOR(ES)

Col, Luciana Saboya Brito Dal; Andrade, Danilo L.; Gon, Lucas M.; Capibaribe, Diego M.; Amaro, Marcelo P.; Truzzi, Natássia C. C.; Malkomes, Barbara R.; Reis, Leonardo O.

FONTE

International braz j urol

DATA DE PUBLICAÇÃO

2022

RESUMO

Documentos Relacionados

• Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
• National Consensus on Non-metastatic Castration-Resistant Prostate Cancer: more than just a snapshot
• Phase I Study of Samarium-153 Lexidronam With Docetaxel in Castration-Resistant Metastatic Prostate Cancer
• Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
• A Transforming Scenario: the New Space Agenda